Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Human Reproduction

• Publication date

  2011-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/humrep/der297PMID 21926054
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A very large proportion of young Danish women have polycystic ovaries: is a revision of the Rotterdam criteria needed?

  2010influential reference
• Polycystic ovaries, as defined by the 2003 Rotterdam consensus criteria, are found to be very common in young healthy women.

  2010cited by this paper
• Development of a second generation anti-Müllerian hormone (AMH) ELISA.

  2010cited by this paper
• The polycystic ovary post-rotterdam: a common, age-dependent finding in ovulatory women without metabolic significance.

  2010influential reference
• Reconciling the definitions of polycystic ovary syndrome: the ovarian follicle number and serum anti-Müllerian hormone concentrations aggregate with the markers of hyperandrogenism.

  2010influential reference
• Asymptomatic volunteers with a polycystic ovary are a functionally distinct but heterogeneous population.

  2009cited by this paper
• Metabolic features of the reproductive phenotypes of polycystic ovary syndrome.

  2009cited by this paper
• Ovarian morphology is a marker of heritable biochemical traits in sisters with polycystic ovaries.

  2008cited by this paper
• Does 3D ultrasound offer any advantage in the pretreatment assessment of ovarian reserve and prediction of outcome after assisted reproduction treatment?

  2007cited by this paper
• Three-dimensional ultrasound features of the polycystic ovary and the effect of different phenotypic expressions on these parameters.

  2007cited by this paper
• Changes in serum anti-mullerian hormone level during low-dose recombinant follicular-stimulating hormone therapy for anovulation in polycystic ovary syndrome.

  2007cited by this paper
• Polycystic ovary syndrome

  2007cited by this paper
• Diagnosis of polycystic ovaries by three-dimensional transvaginal ultrasound.

  2006cited by this paper
• Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline.

  2006influential reference
• Oligoanovulation with polycystic ovaries but not overt hyperandrogenism.

  2006influential reference
• Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome.

  2006influential reference
• Serum Anti-M??llerian Hormone as a Surrogate for Antral Follicle Count for Definition of the Polycystic Ovary Syndrome

  2006influential reference
• Diagnosis of Polycystic Ovarian Syndrome: The Rotterdam Criteria Are Premature

  2006influential reference
• Diagnosis of Polycystic Ovarian Syndrome: In Defense of the Rotterdam Criteria

  2006influential reference
• Revisiting the ovarian volume as a diagnostic criterion for polycystic ovaries.

  2005cited by this paper
• Anti-Müllerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age.

  2004influential reference
• Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

  2004cited by this paper
• Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment.

  2004cited by this paper
• Polycystic ovarian morphology with regular ovulatory cycles: insights into the pathophysiology of polycystic ovarian syndrome.

  2004cited by this paper
• Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest.

  2003cited by this paper
• Ultrasound examination of polycystic ovaries: is it worth counting the follicles?

  2003influential reference
• Ultrasound assessment of the polycystic ovary: international consensus definitions.

  2003cited by this paper
• A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile.

  1999cited by this paper
• The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2000 by The Endocrine Society A Prospective Study of the Prevalence of the Polycystic Ovary Syndrome in Unselected Caucasian Women from Spain*

  1999cited by this paper
• Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine.

  1993influential reference
• Statistical theory in clustering

  1985influential reference
• Rank Transformations as a Bridge between Parametric and Nonparametric Statistics

  1981cited by this paper
• 0021-972X/04/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 89(6):2745–2749 Printed in U.S.A. Copyright © 2004 by The Endocrine Society doi: 10.1210/jc.2003-032046 The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected

  year unknowncited by this paper

• Targeting angiogenesis in endometriosis: a systematic review and network meta-analysis of VEGF-directed pharmacotherapies

  2026cites this paper
• Total Testosterone Measured by Liquid Chromatograph‐Tandem Mass Spectrometry Refines Diagnosis of Biochemical Hyperandrogenism and Better Identifies Subgroup at Genuine Risk of Adverse Fertility Outcomes in Women With Polycystic Ovary Syndrome

  2026cites this paper
• Daughters of PCOS mothers and AMH plasma concentrations in pre-puberty and puberty: A meta-analysis.

  2025cites this paper
• The relationship of antimullerian hormone with severity of clinical symptoms in polycystic ovary syndrome

  2025cites this paper
• Impact of Elevated AMH Levels on Maternal and Perinatal Outcomes in IVF Pregnancies with PCOS

  2025cites this paper
• To Evaluate the Role of Anti-müllerian Hormone as a Novel Biomarker in Polycystic Ovarian Syndrome and its Correlation with Clinical and Hormonal Profile

  2025cites this paper
• Association of Polycystic Ovary Syndrome with Clinical, Physical, and Reproductive Factors: A Data-Driven Analysis

  2025cites this paper
• Evaluating Ovarian Volume as a Diagnostic Marker for Polycystic Ovary Syndrome: A Comparative Study in Iraqi Women

  2025cites this paper
• Metabolic and Hormonal Profile of Insulin-Like Peptide 5 (INSL5) in Polycystic Ovary Syndrome: A Prospective Analysis

  2025cites this paper
• Utility of Polycystic Ovarian Morphology on Ultrasonography Across Menstrual Cycle Phases to Aid in the Diagnosis of Polycystic Ovary Syndrome (PCOS)

  2025cites this paper
• Exploring the diagnostic potential of micro-RNA-320 and anti-Müllerian hormone in women with polycystic ovary syndrome ‒ a case-control study

  2025cites this paper
• Oncological safety and fertility outcomes of controlled ovarian stimulation in patients with early-stage endometrial cancer

  2025cites this paper
• Maternal and paternal smoking and offspring antral follicle count in women from an infertility clinic.

  2025cites this paper
• The role of anti-Müllerian hormone: insights into ovarian reserve, primary ovarian insufficiency, and menopause prediction

  2025cites this paper
• Infertilidad femenina de origen endocrino

  2025cites this paper
• GnRH ability to release FSH and LH in women with functional hypothalamic amenorrhea: a retrospective cohort study about women with and without polycystic ovarian morphology

  2025cites this paper
• Comprehensive Review of Genital Tuberculosis: Epidemiological Patterns, Causal Agents, Diagnostic Strategies, Symptomatology and Fertility Consequences

  2025cites this paper
• Prevalence of Polycystic Ovarian Syndrome in Women of Reproductive Age in Mymensingh Region of Bangladesh – A Sonographic Evaluation

  2025cites this paper
• Impact of updated international diagnostic criteria for diagnosis of polycystic ovary syndrome (PCOS) among Asian‐Indian women—a cross‐sectional study

  2025cites this paper
• Recalibrating Anti-Müllerian Hormone (AMH) reference ranges: a clinical and psychosocial imperative.

  2025cites this paper
• In vitro maturation in subfertile women with polycystic ovarian syndrome undergoing assisted reproduction.

  2025cites this paper
• Evaluating AFC and Hormonal Profiles in Infertility: Insights into PCOS Diagnosis in Samawa City, Iraq

  2025cites this paper
• Infertility Prediction using Long Short-Term Memory Algorithm with PCOS Electronic Healthcare Data

  2025cites this paper
• Knowledge, Attitude, and Practice of Polycystic Ovarian Syndrome Diagnosis among Health Care Providers in Addis Ababa, Ethiopia

  2025cites this paper
• Phenotypic Variations in Polycystic Ovary Syndrome: Metabolic Risks and Emerging Biomarkers.

  2025cites this paper
• Functional hypothalamic amenorrhoea and polycystic ovarian morphology: a narrative review about an intriguing association

  2024cites this paper
• Metabolic and endocrine changes induced by cinnamon in women with polycystic ovarian syndrome: A pilot study

  2024cites this paper
• Sunnah Foods for the treatment of Infertility in women with PCOS: A Literature Review

  2024cites this paper
• Validation of the follicular and ovarian thresholds by an 18-MHz ultrasound imaging in polycystic ovary syndrome: a pilot cutoff for North African patients

  2024influential citation
• Hiperandrogenismo en la adolescente

  2024cites this paper
• Predicting ART outcomes: The role of ovarian RAS and VEGF in follicular fluid of dominant follicles.

  2024cites this paper
• Exploring the Role of Ultrasound for Diagnosing Polycystic Ovary Syndrome in Women in Najran, Saudi Arabia

  2024cites this paper
• Anti-Mullerian Hormone According to Polycystic Ovary Syndrome Phenotypes

  2024cites this paper
• Anti-Müllerian hormone: biology and role in endocrinology and cancers

  2024cites this paper
• Clinical and Demographic Characteristics of Patients Diagnosed with Polycystic Ovary Syndrome: A Cross-Sectional Observational Study

  2024cites this paper
• Unmet clinical needs in women with polycystic ovary syndrome in regard to mental health: a cross-sectional study

  2024cites this paper
• Influence of state-of-the-art laboratory techniques on the phenotyping of women with polycystic ovary syndrome in the clinical setting

  2024cites this paper
• Is it useful to measure DHEAS levels in PCOS?

  2024cites this paper
• Study of Anti-mullerian Hormone as a Diagnostic Criteria for Polycystic Ovarian Syndrome

  2024cites this paper
• Prenatal phthalate exposure and pubertal development in 16-year-old daughters: reproductive hormones and number of ovarian follicles.

  2024cites this paper
• Hyperandrogénie chez l’adolescente

  2024cites this paper
• Pulsatile GnRH therapy: comparison of efficacy between Functional Hypothalamic Amenorrhea and Congenital Hypogonadotropic Hypogonadism.

  2024cites this paper
• Phenotypes Associated With Polycystic Ovary Syndrome Risk Variants

  2024cites this paper
• Utility of Serum Anti-Müllerian Hormone Measurement as Part of Polycystic Ovary Syndrome Diagnosis

  2024cites this paper
• Anti-Müllerian hormone as a diagnostic biomarker for Polycystic Ovary Syndrome (PCOS) and Polycystic Ovarian Morphology (PCOM): a systematic review and meta-analysis.

  2024cites this paper
• Menstrual abnormalities effects on clinical features and in vitro fertilization pregnancy outcomes in women with polycystic ovarian syndrome

  2024cites this paper
• Evaluation of Predictors of Response to Ovulation Induction Using Letrozole in Women with Polycystic Ovary Syndrome: A Prospective Cohort Study

  2024cites this paper
• Ultrasonographic threshold of ovarian structure in premenopausal women of different ethnicity

  2024cites this paper
• New insights into the relationship between Anti-Mullerian Hormone and Polycystic ovary syndrome and its diagnostic accuracy: An updated and extended meta-analysis using marginal beta-binomial model.

  2024cites this paper
• Current Guidelines for Diagnosing PCOS

  2023cites this paper
• Changes in circulating forms of anti-Muüllerian hormone and androgens in women with and without PCOS: a systematic longitudinal study throughout pregnancy

  2023cites this paper
• An artificial intelligence-based decision support system for early diagnosis of polycystic ovaries syndrome

  2023cites this paper
• Serum LH levels are associated to serum insulin and Anti‐Müllerian hormone levels in women with both functional hypothalamic amenorrhoea and polycystic ovarian morphology

  2023cites this paper
• Diagnostic Performance of Ovarian Morphology on Ultrasonography across Anovulatory Conditions—Impact of Body Mass Index

  2023cites this paper
• A Narrative Review Discussing the Efficiency of Personalized Dosing Algorithm of Follitropin Delta for Ovarian Stimulation and the Reproductive and Clinical Outcomes

  2023cites this paper
• Hypothalamic neuroglial plasticity is regulated by anti-Müllerian hormone and disrupted in polycystic ovary syndrome.

  2023cites this paper
• Serum Anti-Mullerian Hormone (AMH) Levels Among Different PCOS Phenotypes and Its Correlation with Clinical, Endocrine, and Metabolic Markers of PCOS

  2023influential citation
• How to Choose the Optimal Starting Dose of Clomiphene Citrate (50 or 100 mg per Day) for a First Cycle of Ovulation Induction in Anovulatory PCOS Women?

  2023influential citation
• Effect of laparoscopic ovarian drilling on ovulation rate in women with clomiphene resistant polycystic ovarian syndrome

  2023cites this paper
• Anti-Müllerian Hormone Level Predicts Ovulation in Women with Polycystic Ovary Syndrome Treated with Clomiphene and Metformin.

  2023cites this paper
• Polycystic ovary syndrome v.2023: Simplified diagnostic criteria for an East Asian phenotype.

  2023cites this paper
• Serum anti-Müllerian hormone: A potential biomarker for polycystic ovary syndrome

  2023influential citation
• Value of Assessing AMH in the Management of Polycystic Ovarian Syndrome (PCOS)

  2023cites this paper
• Ultrasonographic criteria in the diagnosis of polycystic ovary syndrome: a systematic review and diagnostic meta-analysis.

  2023cites this paper
• The role of anti-Mullerian hormone and other correlates in patients with polycystic ovary syndrome

  2023cites this paper
• The Effect of Latent Tuberculosis Infection on Ovarian Reserve and Pregnancy Outcomes among Infertile Women Undergoing Intrauterine Insemination: A Retrospective Cohort Study with Propensity Score Matching

  2023cites this paper
• Normative cut-offs for polycystic ovary syndrome (PCOS) diagnostic features in adolescents using cluster analysis.

  2023cites this paper
• Polycystic Ovary Syndrome: Pathophysiology and Controversies in Diagnosis

  2023cites this paper
• Diagnostic Accuracy of Anti-Mullerian Hormone for Polycystic Ovary Syndrome

  2023cites this paper
• Determining the age group-based cut-off values of serum anti-Mullerian hormone concentrations to diagnose polycystic ovary syndrome

  2023cites this paper
• Association between serum AMH levels and IVF/ICSI outcomes in patients with polycystic ovary syndrome: a systematic review and meta-analysis

  2023cites this paper
• Benefits of physical activity on reproductive health functions among polycystic ovarian syndrome women: a systematic review

  2023cites this paper
• Prevalence of Polycystic Ovarian Syndrome in India: A Systematic Review and Meta-Analysis

  2022cites this paper
• The physiological sonographic features of the ovary in healthy subjects: a joint systematic review and meta-analysis by the Italian Society of Gynecology and Obstetrics (SIGO) and the Italian Society of Endocrinology (SIE)

  2022cites this paper
• Impact of updated international diagnostic criteria for the diagnosis of polycystic ovary syndrome

  2022cites this paper
• Efficacy of serum anti-mullerian hormone (AMH) levels for prediction of polycystic ovary syndrome (PCOS) and its association with clinical, biochemical and hormonal parameters

  2022cites this paper
• The Disparity in the Management of Polycystic Ovary Syndrome between Obstetrician-Gynecologists in Different-Level Hospitals under the Hierarchical Medical System

  2022cites this paper
• The diagnostic performance of antimullerian hormone for polycystic ovarian syndrome and polycystic ovarian morphology

  2022cites this paper
• Comparison of body mass index, anti-müllerian hormone and insulin resistance parameters among different phenotypes of polycystic ovarian syndrome

  2022cites this paper
• General infertility workup in times of high assisted reproductive technology efficacy.

  2022cites this paper
• Anti-Müllerian hormone levels in the diagnosis of adolescent polycystic ovarian syndrome: a systematic review and meta-analysis.

  2022cites this paper
• Impact of increasing antimüllerian hormone level on in vitro fertilization fresh transfer and live birth rate

  2022cites this paper
• Anti Mullerian hormone as a diagnostic tool for polycystic ovary syndrome in women of reproductive age with morbid obesity

  2022cites this paper
• Basal and dynamic relationships between serum anti-Müllerian hormone and gonadotropins in patients with functional hypothalamic amenorrhea, with or without polycystic ovarian morphology

  2022cites this paper
• Analysis of Treatment Outcomes of Infertile Japanese Women Based on Serum Anti-Müllerian Hormone Levels to Investigate Its Criteria in Infertile Practice

  2022cites this paper
• Syndrome des ovaires polykystiques

  2022cites this paper
• Updated meta‐analysis on the diagnostic accuracy of serum anti‐Mullerian hormone in poly cystic ovary syndrome involving 13 509 subjects

  2022cites this paper
• Méthodes d’exploration de la fonction ovarienne

  2022cites this paper
• Effects of Different Ovulation Induction Regimens on Sex Hormone Levels and Serum CTRP3 and CTRP15 Levels in Patients with Polycystic Ovary Syndrome (PCOS)

  2022cites this paper
• The effect of the polycystic ovary syndrome and hypothyroidism on the risk of fibrocystic breast changes: a meta-analysis

  2022cites this paper
• Serum anti-Müllerian hormone as a predictor of polycystic ovarian syndrome among women of reproductive age

  2022cites this paper
• Diagnostic values of MRI indexes for polycystic ovary syndrome

  2022cites this paper
• Hormonal status and bone turnover in adolescents with polycystic ovarian syndrome

  2022cites this paper
• Comparison of two endometrial preparation methods for frozen-thawed embryo transfer in anovulatory PCOS patients: impact on miscarriage rate.

  2022cites this paper
• In Vitro Maturation of Oocytes

  2022cites this paper
• Is anti-Mullerian hormone a useful biomarker in the diagnosis of polycystic ovary syndrome in Chinese adolescents?

  2022cites this paper
• An update on polycystic ovary syndrome: A review of the current state of knowledge in diagnosis, genetic etiology, and emerging treatment options

  2022cites this paper
• Endocrine disorders of the reproductive system

  2021cites this paper
• Anti-Müllerian Hormone in Pathogenesis, Diagnostic and Treatment of PCOS

  2021cites this paper
• Substituting serum anti-Müllerian hormone for polycystic ovary morphology increases the number of women diagnosed with polycystic ovary syndrome: a community-based cross-sectional study.

  2021cites this paper